The Centers for Disease Control and Prevention is one step closer to recommending the RSV vaccine for adults 65 years and older. The agency's vaccine advisory committee voted 9-2 this week in favor of ...

After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way. On Wednesday, the US Food and Drug Administration ...

Amid a surprisingly severe flu season and a COVID-19 resurgence, those highly contagious respiratory illnesses are drawing ...

Infant protection against respiratory syncytial virus (RSV) by maternal RSV vaccination or receipt of RSV monoclonal antibody ...

The season of never-ending sneezing and stuffy noses is underway, sending Americans to pharmacy lines in hopes of keeping illness at bay with yearly shots. While flu and COVID-19 vaccines are an ...

"Current vaccine recommendations continue to stratify by age but need to better incorporate risk from the presence of chronic medical conditions at any age." — Angela Branche, MD, Associate Professor ...

LET'S BE CLEAR: The primary reason to be vaccinated against shingles is that two shots provide at least 90% protection ...

-- Results indicate potential best-in-class RSV+hMPV±PIV3 combination vaccines, with the potential ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden ...

Cases of respiratory syncytial virus are increasing, but vaccines and antibody shots can keep young children out of the ...